Muscle is a savings account spent in old age. From about fifty, adults lose one to two percent of muscle mass yearly, faster after illness or inactivity. When loss crosses into weakness and poor function, the condition is sarcopenia, formally recognized as a disease with its own diagnosis code since 2016.

The Five Questions

SARC-F spells its own content. Strength asks about lifting five kilograms, assistance about walking across a room, rise about getting out of a chair, climb about a flight of stairs, and falls about tumbles in the past year. Each earns zero, one or two points, and the sum reaches ten. Four or more is the validated positive screen, carrying high specificity though modest sensitivity, meaning positives are usually real while some cases slip through.

Why Screening Matters Early

Sarcopenia compounds silently. Less muscle means less activity, which means less muscle, and the spiral typically surfaces only after a fracture or a failed recovery from routine illness. Caught at the screen positive stage, progressive resistance training two to three times weekly plus protein intake near one point two grams per kilogram daily reverses measurable function in most trials within months.

Confirming the Diagnosis

European consensus confirms sarcopenia with low grip strength or chair stand performance plus low muscle quantity on DEXA or bioimpedance. Severe disease adds poor gait speed. The screen’s job is simply deciding who earns those tests.

Protein distribution matters as much as total, twenty five to thirty grams per meal stimulates muscle building better than the same total skewed to dinner, a pattern worth building early.

References

• Malmstrom TK et al. SARC-F, a symptom score to predict persons with sarcopenia at risk
• Cruz-Jentoft AJ et al. Sarcopenia, revised European consensus EWGSOP2